Related Experiment Videos

Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR

S Goldstone1, S Pavey, A Forrest

  • 1Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, and Joint Experimental Oncology Program, Department of Pathology, University of Queensland, Brisbane, QLD, Australia.

Oncogene
|April 21, 2001
PubMed

Insights

Cyclin A/cdk2 activity during G2 phase is regulated by cdc25. DNA damage blocks this activation, suggesting a role in the G2 checkpoint control.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin A/cdk2 plays a role in cell cycle regulation.
  • Its function and regulation during the G2 phase remain unclear.

Purpose of the Study:

  • To investigate the regulation of cyclin A/cdk2 activity during normal G2 phase progression.
  • To understand its role in genotoxin-induced G2 arrest.

Main Methods:

  • Examined cyclin A/cdk2 activity during G2 phase.
  • Studied G2 arrest induced by DNA damage.
  • Assessed the role of cdc25 isoforms (cdc25B, cdc25C) and ATM/ATR signaling.

Main Results:

  • Cyclin A/cdk2 is activated in early G2 by cdc25.
  • DNA damage-induced G2 arrest blocks cdc25-dependent activation of cyclin A/cdk2 and cyclin B1/cdc2.
  • Ectopic expression of cdc25B, not cdc25C, reactivates both cyclin complexes.
  • The block in activation is independent of ATM/ATR signaling.

Conclusions:

  • The G2 checkpoint prevents cyclin A/cdk2 activation in a manner independent of ATM/ATR.
  • This ATM/ATR-independent block may represent an additional layer of checkpoint control.
  • Inhibition of G2 phase cyclin A/cdk2 activation contributes to the G2 checkpoint arrest.

Related Concept Videos